189 related articles for article (PubMed ID: 23930739)
1. Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis.
Armstrong AC; Gjesdal O; Almeida A; Nacif M; Wu C; Bluemke DA; Brumback L; Lima JA
Echocardiography; 2014; 31(1):12-20. PubMed ID: 23930739
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
Jakubovic BD; Wald R; Goldstein MB; Leong-Poi H; Yuen DA; Perl J; Lima JA; Liu JJ; Kirpalani A; Dacouris N; Wald R; Connelly KA; Yan AT
Can J Cardiol; 2013 Mar; 29(3):384-90. PubMed ID: 23103220
[TBL] [Abstract][Full Text] [Related]
3. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice.
Armstrong AC; Gidding S; Gjesdal O; Wu C; Bluemke DA; Lima JA
JACC Cardiovasc Imaging; 2012 Aug; 5(8):837-48. PubMed ID: 22897998
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
Ruebner RL; Ng D; Mitsnefes M; Foster BJ; Meyers K; Warady B; Furth SL
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1962-1968. PubMed ID: 27630183
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Left Ventricular Mass and Hypertrophy by Cardiovascular Magnetic Resonance Imaging in Pediatric Hypertension.
Supe-Markovina K; Nielsen JC; Musani M; Panesar LE; Woroniecki RP
J Clin Hypertens (Greenwich); 2016 Oct; 18(10):976-981. PubMed ID: 26988578
[TBL] [Abstract][Full Text] [Related]
6. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.
Arnold R; Schwendinger D; Jung S; Pohl M; Jung B; Geiger J; Gimpel C
Pediatr Nephrol; 2016 Feb; 31(2):255-65. PubMed ID: 26342304
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance.
Chirinos JA; Segers P; De Buyzere ML; Kronmal RA; Raja MW; De Bacquer D; Claessens T; Gillebert TC; St John-Sutton M; Rietzschel ER
Hypertension; 2010 Jul; 56(1):91-8. PubMed ID: 20458004
[TBL] [Abstract][Full Text] [Related]
9. Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).
Chrispin J; Jain A; Soliman EZ; Guallar E; Alonso A; Heckbert SR; Bluemke DA; Lima JA; Nazarian S
J Am Coll Cardiol; 2014 May; 63(19):2007-13. PubMed ID: 24657688
[TBL] [Abstract][Full Text] [Related]
10. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
Seo HY; Lee SP; Park JB; Lee JM; Park EA; Chang SA; Kim HK; Park SJ; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Choe YH
J Am Soc Echocardiogr; 2015 Oct; 28(10):1194-1203, e2. PubMed ID: 26194306
[TBL] [Abstract][Full Text] [Related]
11. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging.
Patel RK; Oliver S; Mark PB; Powell JR; McQuarrie EP; Traynor JP; Dargie HJ; Jardine AG
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1477-1483. PubMed ID: 19713289
[TBL] [Abstract][Full Text] [Related]
12. Calculation of pediatric left ventricular mass: validation and reference values using real-time three-dimensional echocardiography.
Laser KT; Houben BA; Körperich H; Haas NA; Kelter-Klöpping A; Barth P; Burchert W; DallaPozza R; Kececioglu D; Herberg U
J Am Soc Echocardiogr; 2015 Mar; 28(3):275-83. PubMed ID: 25533192
[TBL] [Abstract][Full Text] [Related]
13. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
Cuspidi C; Giudici V; Negri F; Meani S; Sala C; Zanchetti A; Mancia G
J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252
[TBL] [Abstract][Full Text] [Related]
14. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular mass and atrial volume determined by cine magnetic resonance imaging in essential hypertension.
Mineoi K; Shigematsu Y; Ochi T; Hiwada K
Am J Hypertens; 2000 Oct; 13(10):1103-9. PubMed ID: 11041165
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass.
Vitale G; Galderisi M; Pivonello R; Spinelli L; Ciccarelli A; de Divitiis O; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2004 Mar; 60(3):343-9. PubMed ID: 15009000
[TBL] [Abstract][Full Text] [Related]
17. Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification.
Brumback LC; Kronmal R; Heckbert SR; Ni H; Hundley WG; Lima JA; Bluemke DA
Int J Cardiovasc Imaging; 2010 Apr; 26(4):459-68. PubMed ID: 20107905
[TBL] [Abstract][Full Text] [Related]
18. Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension.
Burns J; Sivananthan MU; Ball SG; Mackintosh AF; Mary DA; Greenwood JP
Circulation; 2007 Apr; 115(15):1999-2005. PubMed ID: 17389264
[TBL] [Abstract][Full Text] [Related]
19. Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy.
Szwejkowski BR; Gandy SJ; Rekhraj S; Houston JG; Lang CC; Morris AD; George J; Struthers AD
J Am Coll Cardiol; 2013 Dec; 62(24):2284-93. PubMed ID: 23994420
[TBL] [Abstract][Full Text] [Related]
20. Assessment of left ventricular mass regression after aortic valve replacement--cardiovascular magnetic resonance versus M-mode echocardiography.
Rajappan K; Bellenger NG; Melina G; Di Terlizzi M; Yacoub MH; Sheridan DJ; Pennell DJ
Eur J Cardiothorac Surg; 2003 Jul; 24(1):59-65. PubMed ID: 12853046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
